Embryonic stem cell research is already provided for in the EU framework programme. Financial resources have been provided for it within the overall allocation for genomics and biotechnology for health since the decision of December 2001. What is missing are guidelines and safeguards and this is precisely and only what the Commission's proposal now provides.